[1] Albiero R, Burzotta F, Lassen JF, et al.Treatment of coronary bifurcation lesions, part I: implanting the first stent in the provisional pathway. The 16th expert consensus document from the European bifurcation club[J]. EuroInterv. 2022; 18(5): e362-e376.
[2] 黄启贤. 切割球囊联合药物涂层球囊在冠状动脉分叉病变分支血管保护中的临床应用[D].新疆医科大学,2022.DOI:10.27433/d.cnki.gxyku.2022.000104.
[3] 于江川. 药物涂层球囊用于冠状动脉分叉病变分支血管疗效的Meta分析[D].重庆医科大学,2022.DOI:10.27674/d.cnki.gcyku.2022.001591.
[4] 吴志豪,王思,彭杨威,等.药物洗脱球囊在冠状动脉狭窄病变合并远端心肌桥治疗中的效果观察[J].山东医药,2022,62(34):68-71.
[5] 崔哲,高超,张富洋,等.切割或棘突球囊预扩张对药物涂层球囊治疗冠状动脉病变预后影响[J].心脏杂志,2024,36(03):262-265,270.
[6] 《药物涂层球囊在临床应用中国专家共识(第二版)》专家组,药物涂层球囊在临床应用中国专家共识(第二版)[J],中国介入心脏病学杂志,2023,31(6),413-426.
[7] Mathey DG, Wendig I, Boxberger M, Bonaventura K, Kleber FX. Treatment of bifurcation lesions with a drug-eluting balloon: the PEPCAD V (Paclitaxel Eluting PTCA Balloon in Coronary Artery Disease) trial.EuroIntervention.2011;7 Suppl K:K61-K65.
[8] Lassen JF, Holm NR, Stankovic G, et al.Percutaneous coronary intervention for coronary bifurcation disease: consensus from the first 10 years of the European Bifurcation Club meetings[J]. EuroIntervention, 2014, 10(5): 545-60.doi:10.4244/eijv10i5a97.
[9] Chen X, Li X, Zhang JJ, et al.3-Year Outcomes of the DKCRUSH-V Trial Comparing DK Crush With Provisional Stenting for Left Main Bifurcation Lesions[J]. 2019, 12(19): 1927-37.doi:10.1016/j.jcin.2019.04.056. |
